Package 0406-5112-01

Brand: lisdexamfetamine dimesylate

Generic: lisdexamfetamine dimesylate
NDC Package

Package Facts

Identity

Package NDC 0406-5112-01
Digits Only 0406511201
Product NDC 0406-5112
Product ID 0406-5112_b4be564a-404d-4ca1-bac0-ec9cf40fef93
Description

100 CAPSULE in 1 BOTTLE (0406-5112-01)

Marketing

Marketing Status
Marketed Since 2023-08-25
Brand lisdexamfetamine dimesylate
Generic lisdexamfetamine dimesylate
Sample Package No

Linked Drug Pages (1)

Lisdexamfetamine Dimesylate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b4be564a-404d-4ca1-bac0-ec9cf40fef93", "openfda": {"upc": ["0304065112013", "0304065117018", "0304065116011", "0304065115014", "0304065111016", "0304065113010", "0304065114017"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["806a1c15-0842-4787-b2ad-09a21fd96b37"], "manufacturer_name": ["SpecGx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0406-5112-01)", "package_ndc": "0406-5112-01", "marketing_start_date": "20230825"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "0406-5112_b4be564a-404d-4ca1-bac0-ec9cf40fef93", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0406-5112", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine Dimesylate", "labeler_name": "SpecGx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "20 mg/1"}], "application_number": "ANDA211840", "marketing_category": "ANDA", "marketing_start_date": "20230825", "listing_expiration_date": "20261231"}